Catalyst Pharmaceuticals
CPRX
#4094
Rank
ยฃ2.04 B
Marketcap
ยฃ16.67
Share price
-1.40%
Change (1 day)
-2.23%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2025 (TTM): ยฃ0.21 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.57 Billion. In 2024 the company made an earning of ยฃ0.16 Billion, an increase over its 2023 earnings that were of ยฃ70.86 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.21 B34.19%
2024 ยฃ0.16 B128.82%
2023 ยฃ70.86 M-9.75%
2022 ยฃ78.51 M98.83%
2021 ยฃ39.49 M25.73%
2020 ยฃ31.4 M25.38%
2019 ยฃ25.05 M-198.25%
2018 -ยฃ25.5 Million84.68%
2017 -ยฃ13.81 Million1.88%
2016 -ยฃ13.56 Million-10.68%
2015 -ยฃ15.18 Million30.46%
2014 -ยฃ11.63 Million27.6%
2013 -ยฃ9.12 Million198.17%
2012 -ยฃ3.06 Million-36.22%
2011 -ยฃ4.8 Million59.52%
2010 -ยฃ3.01 Million-44.68%
2009 -ยฃ5.44 Million-31.45%
2008 -ยฃ7.93 Million155.21%
2007 -ยฃ3.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
ยฃ0.50 B 137.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ0.19 Billion-188.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.29 B 11,235.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-ยฃ0.21 Billion-195.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.88 B 4,047.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.10 B 2,747.50%๐Ÿ‡บ๐Ÿ‡ธ USA